A restriction map of the 272-kb IncHI2 plasmid R478 was constructed by using the enzymes ApaI, XbaI, Sail, and XhoI. The map was derived from cloned restriction fragments from R478 inserted into cosmid and plasmid vectors as well as from double-digestion analysis of R478 and R478 miniplasmids. All previously known resistance determinants were cloned from R478, and their positions were located on the restriction map. A region involved in incompatibility was cloned and mapped. The location of a previously unreported arsenite resistance gene was also determined. The genes encoding tellurite resistance, colicin B resistance, and phage inhibition were found to be associated with a 6.7-kb Sail fragment of R478.The first reported isolation of a plasmid of the H incompatibility group was from the chloramphenicol-resistant Salmonella typhi strain responsible for the 1972 Mexican typhoid epidemic (2). IncH plasmids have since been shown to encode for multiple drug and metal resistances in bacteria of the family Enterobacteriaceae (1,31,36 30°C (25, 36). IncHII plasmids differ from IncHI plasmids in that they are nonthermosensitive for transfer, are not repressed for pilus synthesis, and transfer at high frequencies (6).On the basis of DNA-DNA hybridization studies, the IncHI group of plasmids is further divided into three subgroups, IncHIl, IncHI2, and IncHI3 (42 (Table 1). In this paper, we describe the construction of the first restriction map of R478 and indicate locations for several of the genes on this plasmid.
MATERIALS AND METHODSBacterial strains, plasmids, cosmids, and media. All strains, plasmids, and cosmids used in this study are listed in Table 1. E. coli JM109 was used for plasmid cloning by using the vector pUC13. Transformants were isolated on Luria-Bertani (LB) medium containing 20 ,ug of 5-bromo-4-chloro-3-indolyl-o-D-galactopyranoside per ml, 20 jig of isopropyl-P-D-thiogalactopyranoside (Sigma Chemical Co. Ltd.) per ml, and 100 jig of ampicillin per ml (38). E. coli DH1 was used for all other experiments, unless otherwise stated, and all plasmid clones and deletion plasmids were ultimately transformed into this strain. The plasmid R478 was maintained in E. coli J53-2. Antibacterial agents were used at the following concentrations: ampicillin, 100 jig/ml; kanamycin, 100 ,ug! ml; chloramphenicol, 30 ,ug/ml; nalidixic acid, 30 ,ug/ml; tetracycline, 20 ,ug/ml; mercuric chloride, 80 jig/ml; potassium tellurite, 30 ,ug/ml; and rifampin, 50 ,ugIml. All antibacterial plates were made from tryptone soya agar or brain heart infusion agar (Oxoid Ltd.), unless otherwise indicated.Resistance to arsenate was detected by using 3.5% (wt/ vol) sodium arsenate in LB agar plates. Resistance to arsenite was examined by using 0.5% sodium arsenite (12) in brain heart infusion agar plates. Resistance to both arsenic compounds was tested by examining colony formation on